Head-to-head · WeighScore
Embody vs Lean Meds
The verdict
Lean Meds takes it — 81.8/100 to 76.5/100.
Lean Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Lean Meds holds one price at every dose, names four dispensing pharmacies and its compounding class, and undercuts the field on both molecules.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Embody | Lean Meds |
|---|---|---|
| WeighScore | 76.5/100 | 81.8/100 |
| Grade | C | B− |
| Scorecard rank | #52 | #31 |
| Semaglutide | $79/mo (all doses, promotional rate, compounded) | $79/mo (one-month plan, flat at every dose) |
| Tirzepatide | $129/mo (all doses, promotional rate, compounded) | $109/mo (one-month plan, flat at every dose) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #52 · C
Strengths
- Among the lowest flat rates in the compounded segment — $79/mo semaglutide and $129/mo tirzepatide injection at every dose
- Unique compounded oral tirzepatide gum formulation — alternative for patients who prefer not to inject
- Available in all 50 states with no insurance friction
- 24/7 unlimited clinician messaging and dose-adjustment support included
- Medical leadership by Dr. Alan Viglione, board-certified in Internal Medicine
Where it loses points
- The $79 flat rate relies on an auto-applied promo 'locked forever' — list price in the terms is $199/mo and reviewers allege the lock isn't honored
- Compounded only — no FDA-approved brand-name Ozempic, Wegovy, Zepbound, or Mounjaro option
- Pharmacy partners not publicly named — compounding source transparency is limited
- Compounded oral tirzepatide does not have an FDA-approved counterpart, and oral GLP-1 bioavailability remains an active area of clinical debate
Graded #31 · B−
Strengths
- The price holds at every dose — stated as “same price, every dose” — so titration does not raise the bill
- $79 for semaglutide and $109 for tirzepatide on a one-month plan are at the low end of what this ranking records
- States its compounding class in the footer of every page: state-licensed 503A compounding pharmacies
- Names four dispensing pharmacies with addresses and phone numbers, and names the prescribing medical group
- A nutritionist and unlimited check-ins are included, and shipping is free
Where it loses points
- The $49 in the homepage hero is the twelve-month tier, not the month-to-month rate, and the same page carries a “price increases in” countdown with no dated deadline
- A homepage chip reads “no auto rebill” while the Terms describe automatic charging at recurring intervals until canceled
- An “eligible for insurance” chip sits against an FAQ calling the service self-pay and Terms barring reimbursement from any payor
- The refund page signs both “Leanmeds, Inc.” and “Leanmeds LLC”, chooses Florida law and then fixes venue in Fulton County, Georgia
- A satisfaction rating and a member count are published with no platform and no denominator
- No individual clinician or NPI is published — the medical group is named, its clinicians are not
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 536 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.